CCR8 and colorectal cancer: We have recently demonstrated for the first time that an anti-CCR8 antibody armed with alpha particles emitter 225Ac was able to efficiently kill CCR8+ ti-Tregs in CT26 and MC38 murine models of colorectal cancer [7].